Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arbovirus-Associated Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis of Clinical Characteristics, Subtypes, and Vaccine Associations.

Immunity, inflammation and disease·2026
Same author

Rwanda's National Reference Laboratory Operational Capacity during the 2024 Marburg Virus Disease Outbreak Response.

Tropical diseases, travel medicine and vaccines·2026
Same author

Spatial Inequality in Under-Five Children Undernutrition: Evidence From Ethiopia.

Journal of tropical medicine·2026
Same author

Timely Response: Enhancing Africa's Ebola Outbreak Management through Unified Evidence.

QJM : monthly journal of the Association of Physicians·2026
Same author

Can stochastic modelling predict cross-border spread of the Bundibugyo Ebola virus outbreak in Africa?

The Lancet. Infectious diseases·2026
Same author

Imported cases of dengue in Rwanda: A call for One Health integrated surveillance and response system for arboviral diseases.

IJID regions·2026

Related Experiment Video

Updated: May 20, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Strategies for Managing Marburg Virus Disease Outbreaks: Lessons from the Rwanda Outbreak.

Claude Mambo Muvunyi1, Patrick Gad Iradukunda2,3, Pierre Gashema2

  • 1Rwanda Biomedical Centre, Kgali, Rwanda.

Infection and Drug Resistance
|May 19, 2026
PubMed
Summary

The 2024 Marburg Virus Disease (MVD) outbreak in Rwanda offers crucial lessons for global health security. Early detection, strict infection control, and community engagement are vital for managing this lethal hemorrhagic fever.

Keywords:
Marburg virus diseaseRwandacommunity engagementearly detectioninfection controloutbreak managementsurveillancetherapeuticsvaccines

More Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Experiment Videos

Last Updated: May 20, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Marburg Virus Disease (MVD) is a severe viral hemorrhagic fever with high mortality.
  • Outbreaks pose significant public health challenges due to limited medical countermeasures.
  • The 2024 Rwanda outbreak (66 cases, 15 deaths) underscored the need for effective response strategies.

Purpose of the Study:

  • To review key lessons learned from Rwanda's response to the 2024 Marburg Virus Disease outbreak.
  • To identify critical components for effective MVD outbreak management and containment.
  • To provide guidance for global preparedness and future response strategies.

Main Methods:

  • This study is a narrative review of the 2024 Marburg Virus Disease outbreak in Rwanda.
  • It synthesizes information on surveillance, diagnostics, infection control, community engagement, clinical care, therapeutics, and vaccination.

Main Results:

  • Early detection via strengthened surveillance and rapid diagnostics is critical.
  • Strict infection control practices and robust community engagement are essential for trust and cooperation.
  • Rwanda's integrated approach, including supportive care, therapeutics, and investigational vaccines, demonstrated effective outbreak containment.

Conclusions:

  • Resilient health infrastructure, ongoing research, and cross-border collaborations are necessary to mitigate future MVD threats.
  • Lessons from Rwanda's experience offer valuable insights for global preparedness and response.
  • Effective management of Marburg Virus Disease requires a multi-faceted, integrated public health approach.